[Newsroom] Thumbnail GLP1 and AMD Story
June 10, 2025

GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds

Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…

Screen Shot 2023 10 03 at 9.13.51 PM
December 7, 2023

Back with a Roar!: The European VitreoRetinal Society is back after a three-year hiatus

The coveted vitreoretinal conference took place from August 31 to September 3 in Cappadocia, Turkey, and was attended by over…

Discover our fascinating content at issuu

explore